Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

What Is Osteomyelitis?

Osteomyelitis is a bacterial infection of bone that can affect any bone in the body but has particularly severe consequences in the foot — especially in patients with diabetes mellitus, peripheral arterial disease, or immunocompromise. The foot’s complex bony architecture, exposure to weight-bearing mechanical stress, and proximity to the external environment through the plantar skin create conditions where bone infection, once established, is difficult to eradicate without aggressive combined medical and surgical treatment. Foot osteomyelitis is the primary driver of lower extremity amputation in diabetic patients and remains one of the most challenging infections in clinical medicine.

How Foot Osteomyelitis Develops

Contiguous Spread from Diabetic Foot Ulcers

The most common pathway to foot osteomyelitis in the adult population is direct contiguous spread from a diabetic foot ulcer. When a neuropathic or ischemic ulcer penetrates through skin and subcutaneous tissue to reach the underlying bone — often at a bony prominence where the ulcer is located — bacteria colonizing the wound surface gain direct access to the bone. The time from ulcer development to osteomyelitis varies; deep ulcers over bony prominences (metatarsal heads, heel, fifth metatarsal base) can infect the underlying bone within days to weeks of ulcer onset.

Hematogenous Spread

Hematogenous osteomyelitis — bone infection seeded from a bacteremic episode — is less common in adults than children but occurs in immunocompromised patients, intravenous drug users, and those with other sources of bacteremia (dental procedures, urinary tract infections, intravascular catheters). In children, hematogenous osteomyelitis most commonly affects the metaphyses of long bones but can affect foot bones including the calcaneus.

Diagnosis of Foot Osteomyelitis

Probe-to-Bone Test

The probe-to-bone test is a simple, inexpensive, and highly specific clinical examination for osteomyelitis in the context of diabetic foot ulcers. A sterile blunt metallic probe is inserted into the ulcer base; if rigid bone is palpated at the depth of the wound, the positive predictive value for osteomyelitis is approximately 89%. A positive probe-to-bone test is sufficient evidence to begin treating for osteomyelitis while confirmatory imaging is obtained.

MRI

MRI is the gold standard imaging modality for diagnosing foot osteomyelitis, with sensitivity of approximately 90% and specificity of approximately 80%. The infected bone demonstrates low signal on T1 sequences (replacing normal fatty marrow signal) and high signal on STIR or T2 sequences (representing marrow edema and exudate). MRI also delineates the extent of soft tissue infection — identifying abscess, tenosynovitis, septic arthritis, and sinus tract formation — that are critical for surgical planning. The limitation of MRI is cost and contraindication in patients with metallic implants.

Plain X-Rays

Plain X-rays demonstrate osteomyelitis only after bone destruction reaches 30–50% of the cortical mineral content — typically representing 10–21 days of infection. Early osteomyelitis may have entirely normal X-rays. Positive X-ray findings include periosteal reaction, cortical erosion, focal lytic lesions, and — in advanced cases — sequestra (dead bone fragments) and involucrum (surrounding new bone formation). X-rays are obtained first in all cases but their normal appearance does not exclude osteomyelitis.

Bone Biopsy and Culture

Definitive microbiological diagnosis requires bone biopsy with culture. This is essential for targeting antibiotic therapy, as foot osteomyelitis is polymicrobial in a significant proportion of cases (particularly in diabetic patients), and empirical antibiotic regimens may not cover all causative organisms. Bone biopsy is performed percutaneously under fluoroscopic or CT guidance, or intraoperatively at the time of surgical debridement. Cultures should include aerobic, anaerobic, and mycobacterial cultures at minimum.

Organisms Causing Foot Osteomyelitis

Staphylococcus aureus — including methicillin-resistant Staphylococcus aureus (MRSA) — is the most common causative organism in foot osteomyelitis. In diabetic foot ulcer-associated osteomyelitis, polymicrobial infections are common, with gram-negative organisms (Pseudomonas, Proteus, Enterobacteriaceae) and anaerobes found alongside Staphylococcus. Culture-guided therapy targeting identified organisms reduces treatment failure compared to empirical broad-spectrum antibiotics alone.

Treatment: Combined Medical and Surgical Approach

Antibiotic Therapy

Antibiotic treatment of foot osteomyelitis typically requires 6 weeks of therapy — a duration reflecting the time required to achieve sufficient drug penetration into poorly vascularized infected bone and achieve bacterial clearance. For MRSA osteomyelitis, vancomycin intravenously or oral options including linezolid and trimethoprim-sulfamethoxazole (with rifampin augmentation) are used. For methicillin-susceptible Staphylococcus aureus (MSSA), nafcillin or cefazolin intravenously, or dicloxacillin orally, are highly effective. PICC line placement for home intravenous antibiotic therapy through home health services allows outpatient management for stable patients.

Surgical Debridement

Surgical debridement — removal of infected and necrotic bone — is the cornerstone of osteomyelitis treatment when adequate margins can be achieved without unacceptable functional consequences. For metatarsal osteomyelitis, partial or complete metatarsal head and shaft resection removes the infected bone and eliminates the bony prominence that caused the underlying ulcer. For phalangeal osteomyelitis, digital amputation is often the most efficient solution — removing the infected digit eliminates the osteomyelitis and provides wide surgical margins in a single procedure. Calcaneal osteomyelitis is the most technically challenging to debride because of the heel’s importance for ambulatory function; partial calcanectomy sparing the Achilles insertion can preserve weight-bearing ability while achieving surgical cure.

Prognosis and Prevention

With combined surgical debridement and appropriate prolonged antibiotic therapy, remission rates of 70–80% are achievable for foot osteomyelitis. Recurrence is more common in patients with inadequate debridement margins, persistent ischemia, immunosuppression, or inadequate glycemic control. Prevention centers on aggressive diabetic foot ulcer management from the moment of ulcer development — because an ulcer treated early rarely progresses to osteomyelitis, while an ulcer ignored or inadequately treated frequently does. Any diabetic patient with a foot ulcer should be evaluated by a podiatrist promptly, and any ulcer that probes to bone should be treated as osteomyelitis until proven otherwise.

Expert Foot Care — Close to Home

Balance Foot & Ankle serves Southeast Michigan — same-week appointments, most insurance accepted.

Schedule Now

Expert Foot & Ankle Care in Michigan

Dr. Tom Biernacki provides comprehensive podiatric care at Balance Foot & Ankle in Howell and Bloomfield Hills, serving patients throughout Southeast Michigan.

View All Treatment Options | Book Your Appointment | Call (810) 206-1402

Clinical References

1. Thomas MJ, et al. “The population prevalence of foot and ankle pain.” Pain. 2011;152(12):2870-2880.
2. Hill CL, et al. “Prevalence and correlates of foot pain.” J Foot Ankle Res. 2008;1(1):2.
3. Riskowski JL, et al. “Measures of foot function, foot health, and foot pain.” Arthritis Care Res. 2011;63(S11):S229-S236.